Details for New Drug Application (NDA): 205539
✉ Email this page to a colleague
The generic ingredient in DECITABINE is decitabine. There are eighteen drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the decitabine profile page.
Summary for 205539
Tradename: | DECITABINE |
Applicant: | Gland |
Ingredient: | decitabine |
Patents: | 0 |
Pharmacology for NDA: 205539
Mechanism of Action | Nucleic Acid Synthesis Inhibitors |
Suppliers and Packaging for NDA: 205539
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DECITABINE | decitabine | INJECTABLE;INTRAVENOUS | 205539 | ANDA | Sagent Pharmaceuticals | 25021-231 | 25021-231-20 | 1 VIAL in 1 CARTON (25021-231-20) / 10 mL in 1 VIAL |
DECITABINE | decitabine | INJECTABLE;INTRAVENOUS | 205539 | ANDA | Gland Pharma Limited | 68083-528 | 68083-528-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (68083-528-01) / 10 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRAVENOUS | Strength | 50MG/VIAL | ||||
Approval Date: | Nov 23, 2020 | TE: | AP | RLD: | No |
Complete Access Available with Subscription